Length of Stay Comparison between Rivaroxaban and Warfarin in the Treatment of Pulmonary Embolism: Results from a Real-World Observational Cohort Study

Background. Trials have shown that novel oral anticoagulants may decrease length of stay versus warfarin. A comparison of length of stay in the treatment of pulmonary embolism (PE) has not been performed outside post hoc analysis of a large clinical trial. Objective. To evaluate if rivaroxaban decre...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Thrombosis
Main Authors: Roberts, Kirsten M., Knight, Tamara B., Padilla-Tolentino, Eimeira, Murthy, Manasa, Peterson, Evan J.
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi Publishing Corporation 2015
Assuntos:
Clinical Study
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4735940/
https://ncbi.nlm.nih.gov/pubmed/26881071
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/414523
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados